| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
While a poor earnings report and other headwinds have hurt Oscar Health, traders typically buy the dips in OSCR stock.
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Underweight and lowers the price target from $1...
Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Underweight and raises the price target from $11 to $13.
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, today is introducing affordable, tec...
UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Sell and raises the price target from $11 to $12.
New Leverage Shares ETFs allow investors double daily returns on Lululemon, Gemini, and Oscar Health at one of the lowest fees ...